Skip Navigation

This Article
Right arrow Full Text Freely available
Right arrow FREE Full Text (PDF) Freely available
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in ISI Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrow Search for citing articles in:
ISI Web of Science (42)
Right arrowRequest Permissions
Right arrow Disclaimer
Google Scholar
Right arrow Articles by Collins, B. E.
Right arrow Articles by Schnaar, R. L.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Collins, B. E.
Right arrow Articles by Schnaar, R. L.
Social Bookmarking
 Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

Glycobiology, 2000, Vol. 10, No. 1 11-20
© 2000 Oxford University Press

Conversion of cellular sialic acid expression from N-acetyl- to N-glycolylneuraminic acid using a synthetic precursor, N-glycolylmannosamine pentaacetate: inhibition of myelin-associated glycoprotein binding to neural cells

Brian E. Collins1,2, Thomas J. Fralich1, Saki Itonori, Yoshitaka Ichikawa and Ronald L. Schnaar3,4

Departments of Pharmacology and 4Neuroscience, The Johns Hopkins University School of Medicine, Baltimore, MD 21205, USA

Sialic acids are prominent termini of mammalian glycoconjugates and are key binding determinants for cell–cell recog­nition lectins. Binding of the sialic acid–dependent lectin, myelin-associated glycoprotein (MAG), to nerve cells is implicated in the inhibition of nerve regeneration after injury. Therefore, blocking MAG binding to nerve cell sialoglycoconjugates might enhance nerve regeneration. Previously, we reported that certain sialoglycoconjugates bearing N-acetylneuraminic acid (NeuAc) but not N-glycolylneuraminic acid (NeuGc) support MAG binding (Collins et al., 1997a). We now report highly efficient conversion of sialic acids on living neural cells from exclusively NeuAc to predominantly NeuGc using a novel synthetic metabolic precursor, N-glycolylmannosamine pentaacetate (Man­NGc­PA). When NG108–15 neuroblastoma-glioma hybrid cells, which normally express only NeuAc (and bind to MAG), were cultured in the presence of 1 mM ManNGcPA, they expressed 80–90% of their sialic acid precursor pool as NeuGc within 24 h. Within 5 days, 80% of their ganglioside-associated sialic acids and 70% of their glycoprotein-associated sialic acids were converted to NeuGc. Consistent with this result, treatment of NG108–15 cells with ManNGcPA resulted in nearly complete abrogation of MAG binding. These results demonstrate that ManNGcPA treatment efficiently alters the sialic acid structures on living cells, with a commensurate change in recognition by a physiologically important lectin.

1 These two authors contributed equally to this work.

2 Present address: Department of Molecular Biology, The Scripps Research Institute, La Jolla, CA

3 To whom correspondence should be addressed at: Department of Pharmacology and Molecular Sciences, The Johns Hopkins School of Medicine, 725 North Wolfe Street, Baltimore, MD 21205-2185


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?


This article has been cited by other articles:


Home page
Mol. Cell. Biol.Home page
M. Hedlund, P. Tangvoranuntakul, H. Takematsu, J. M. Long, G. D. Housley, Y. Kozutsumi, A. Suzuki, A. Wynshaw-Boris, A. F. Ryan, R. L. Gallo, et al.
N-Glycolylneuraminic Acid Deficiency in Mice: Implications for Human Biology and Evolution
Mol. Cell. Biol., June 15, 2007; 27(12): 4340 - 4346.
[Abstract] [Full Text] [PDF]


Home page
GlycobiologyHome page
A. Varki and T. Angata
Siglecs--the major subfamily of I-type lectins
Glycobiology, January 1, 2006; 16(1): 1R - 27R.
[Abstract] [Full Text] [PDF]


Home page
Proc. Natl. Acad. Sci. USAHome page
M. J. Martin, J. C. Rayner, P. Gagneux, J. W. Barnwell, and A. Varki
Evolution of human-chimpanzee differences in malaria susceptibility: Relationship to human genetic loss of N-glycolylneuraminic acid
PNAS, September 6, 2005; 102(36): 12819 - 12824.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
M. Bardor, D. H. Nguyen, S. Diaz, and A. Varki
Mechanism of Uptake and Incorporation of the Non-human Sialic Acid N-Glycolylneuraminic Acid into Human Cells
J. Biol. Chem., February 11, 2005; 280(6): 4228 - 4237.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
E. J. Kim, S.-G. Sampathkumar, M. B. Jones, J. K. Rhee, G. Baskaran, S. Goon, and K. J. Yarema
Characterization of the Metabolic Flux and Apoptotic Effects of O-Hydroxyl- and N-Acyl-modified N-Acetylmannosamine Analogs in Jurkat Cells
J. Biol. Chem., April 30, 2004; 279(18): 18342 - 18352.
[Abstract] [Full Text] [PDF]


Home page
Proc. Natl. Acad. Sci. USAHome page
S. Goon, B. Schilling, M. V. Tullius, B. W. Gibson, and C. R. Bertozzi
Metabolic incorporation of unnatural sialic acids into Haemophilus ducreyi lipooligosaccharides
PNAS, March 18, 2003; 100(6): 3089 - 3094.
[Abstract] [Full Text] [PDF]


Home page
Proc. Natl. Acad. Sci. USAHome page
H.-H. Chou, T. Hayakawa, S. Diaz, M. Krings, E. Indriati, M. Leakey, S. Paabo, Y. Satta, N. Takahata, and A. Varki
Inactivation of CMP-N-acetylneuraminic acid hydroxylase occurred prior to brain expansion during human evolution
PNAS, September 3, 2002; 99(18): 11736 - 11741.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
J. L. Sonnenburg, H. van Halbeek, and A. Varki
Characterization of the Acid Stability of Glycosidically Linked Neuraminic Acid. USE IN DETECTING DE-N-ACETYL-GANGLIOSIDES IN HUMAN MELANOMA
J. Biol. Chem., May 10, 2002; 277(20): 17502 - 17510.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
C. Oetke, R. Brossmer, L. R. Mantey, S. Hinderlich, R. Isecke, W. Reutter, O. T. Keppler, and M. Pawlita
Versatile Biosynthetic Engineering of Sialic Acid in Living Cells Using Synthetic Sialic Acid Analogues
J. Biol. Chem., February 15, 2002; 277(8): 6688 - 6695.
[Abstract] [Full Text] [PDF]


Home page
ScienceHome page
C. R. Bertozzi and L. L. Kiessling
Chemical Glycobiology
Science, March 23, 2001; 291(5512): 2357 - 2364.
[Abstract] [Full Text]


Home page
GlycobiologyHome page
O. T. Keppler, R. Horstkorte, M. Pawlita, C. Schmidt, and W. Reutter
Biochemical engineering of the N-acyl side chain of sialic acid: biological implications
Glycobiology, February 1, 2001; 11(2): 11R - 18R.
[Abstract] [Full Text] [PDF]


Home page
GlycobiologyHome page
N. W. Charter, L. K. Mahal, D. E. Koshland Jr., and C. R. Bertozzi
Biosynthetic incorporation of unnatural sialic acids into polysialic acid on neural cells
Glycobiology, October 1, 2000; 10(10): 1049 - 1056.
[Abstract] [Full Text] [PDF]



Disclaimer: Please note that abstracts for content published before 1996 were created through digital scanning and may therefore not exactly replicate the text of the original print issues. All efforts have been made to ensure accuracy, but the Publisher will not be held responsible for any remaining inaccuracies. If you require any further clarification, please contact our Customer Services Department.